These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38731156)

  • 1. ALDRESS: A Retrospective Pilot Study to Develop a Pharmacological Causality Algorithm for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    Stewart S; Gómez López de Las Huertas A; Jiménez-González M; Carcas AJ; Borobia AM; Ramírez E
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731156
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment.
    Cabañas R; Calderón O; Ramírez E; Fiandor A; Caballero T; Heredia R; Herranz P; Madero R; Quirce S; Bellón T
    Clin Exp Allergy; 2018 Mar; 48(3):325-333. PubMed ID: 29265576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Biomarker Identification by RNA-Seq Analysis in Antibiotic-Related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Pilot Study.
    Teo YX; Haw WY; Vallejo A; McGuire C; Woo J; Friedmann PS; Polak ME; Ardern-Jones MR
    Toxicol Sci; 2022 Aug; 189(1):20-31. PubMed ID: 35703984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine in the Treatment of Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: Retrospective Cohort Study.
    Zita S; Broussard L; Hugh J; Newman S
    JMIR Dermatol; 2023 Jul; 6():e41391. PubMed ID: 37632913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility and Safety of Skin Tests in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Systematic Review.
    Teo YX; Friedmann PS; Polak ME; Ardern-Jones MR
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):481-491.e5. PubMed ID: 36154897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome.
    Cabañas R; Ramírez E; Sendagorta E; Alamar R; Barranco R; Blanca-López N; Doña I; Fernández J; Garcia-Nunez I; García-Samaniego J; Lopez-Rico R; Marín-Serrano E; Mérida C; Moya M; Ortega-Rodríguez NR; Rivas Becerra B; Rojas-Perez-Ezquerra P; Sánchez-González MJ; Vega-Cabrera C; Vila-Albelda C; Bellón T
    J Investig Allergol Clin Immunol; 2020; 30(4):229-253. PubMed ID: 31932268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review.
    Awad A; Goh MS; Trubiano JA
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1856-1868. PubMed ID: 36893848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug reaction with eosinophilia and systemic symptoms in a paediatric population: Interest of skin tests.
    Ben Romdhane H; Fadhel NB; Chadli Z; Chaabane A; Benzarti W; Fredj NB; Aouam K
    Contact Dermatitis; 2023 Dec; 89(6):488-495. PubMed ID: 37731315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
    Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
    Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature.
    Metterle L; Hatch L; Seminario-Vidal L
    Pediatr Dermatol; 2020 Jan; 37(1):124-129. PubMed ID: 31691347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
    de Groot AC
    Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F; Asada H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.
    Taweesedt PT; Nordstrom CW; Stoeckel J; Dumic I
    Biomed Res Int; 2019; 2019():7863815. PubMed ID: 31662996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
    Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
    Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interferon-γ-induced protein 10/CXCR3 axis is associated with human herpesvirus-6 reactivation and the development of sequelae in drug reaction with eosinophilia and systemic symptoms.
    Yang CW; Cho YT; Hsieh YC; Hsu SH; Chen KL; Chu CY
    Br J Dermatol; 2020 Nov; 183(5):909-919. PubMed ID: 32037509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Danjuma MI; Naseralallah LMA; AbouJabal B; Mohamed MF; Abubeker IY; Jabbar LA; Elzouki A
    Sci Rep; 2021 Sep; 11(1):17887. PubMed ID: 34504198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.
    Sharifzadeh S; Mohammadpour AH; Tavanaee A; Elyasi S
    Eur J Clin Pharmacol; 2021 Mar; 77(3):275-289. PubMed ID: 33025080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, biochemical, and serologic predictors of drug reaction with eosinophilia and systemic symptoms syndrome: A prospective case-control study.
    Choudhary R; Vinay K; Srivastava N; Bishnoi A; Kamat D; Parsad D; Bhatia A; Kumaran MS
    J Am Acad Dermatol; 2021 Oct; 85(4):901-909. PubMed ID: 33785387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.